Efficacy of Stimulants in Adult ADHD

Annals of Pharmacotherapy

Volumn 37, Issue 12, 2003, Pages 1884-1890

  Maidment, Ian D ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Adult ADHD; Amphetamines; Methylphenidate; Pemoline; Stimulants

Indexed keywords

AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE;

AGITATION; ANXIETY DISORDER; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DRUG EFFICACY; DYSPHORIA; EVALUATION; HEART PALPITATION; HUMAN; INSOMNIA; MEDLINE; METHODOLOGY; MOTOR DYSFUNCTION; MUSCLE TONE; NAUSEA; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; STATISTICAL ANALYSIS; VOMITING; XEROSTOMIA;

ADULT; AMPHETAMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS; HUMANS; PEMOLINE;

EID: 0344844500     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D028     Document Type: Review

References (32)

1. Gadow KD, Weiss M. Attention-deficit/hyperactivity disorder in adults - beyond controversy. Arch Gen Psychiatry 2001;58:784-5.
2. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon S, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-43.
3. Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder residual type, in adults. Am J Psychiatry 1985;142:547-52.
4. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984;41:1059-63.
5. Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, et al. Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 2001;13:129-34.
6. Flavia Dorrego M, Canevaro L, Kuzis G, Sabe L, Starkstein SE. A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J Neuropsychiatry Clin Neurosci 2002;14:289-95.
7. Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR, Lockhart N, et al. Double-blind, placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002;10:286-94.
8. Paterson R, Douglas G, Hallmayer J, Hagan M, Krupenia Z. A randomised, double-blind, placebo-controlled trial of dextroamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 1999;33:494-502.
9. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001;58:775-82.
10. Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult-attention-deficit/hyperactivity disorder. J Clin Psychiatry 2000;61:414-7.
11. Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 2000;10:311-20.
12. Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2001;21:223-8.
13. Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, et al. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 1999;19:257-64.
14. Heiligenstein E, Johnston HF, Nielsen JK. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study. J Am Coll Health 1996;45:35-9.
15. Diagnostic and statistical manual of mental disorders. 3rd ed. revised. Washington, DC: American Psychiatric Association, 1987.
16. Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York, Guildford: 1990.
17. National Institute of Mental Health. CGI (Clinical Global Impression) scale. Psychopharmacol Bull 1985;21:839-43.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:53-63.
20. Hamilton M. The assessment of anxiety scales by rating. Br J Med Psychol 1959;32:50-5.
21. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-71.
22. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1984.
23. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
24. DuPaul GJ. Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychol 1991;20:245-53.
25. Tiffany ST, Singleton E, Haertzen CA, Henningfield JE. The development of a cocaine craving questionnaire. Drug Alcohol Depend 1993;34:19-28.
26. Derogatis LR. Brief Symptom Inventory. Administration scoring, procedures manual. Minneapolis: National Computer Systems Inc., 1993.
27. Brown TE. Brown Attention-Deficit Disorder scales. San Antonio, TX: The Psychological Corporation, 1996.
28. Copeland ED. Copeland Symptom Checklist for adult attention deficit disorders. Atlanta: Southeastern Psychological Institute, 1989.
29. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. Yale-Brown obsessive compulsive scale. Arch Gen Psychiatry 1989;11:1006-11.
30. Shaffer D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry 1994;154:633-8.
31. Wender PH, Reimherr FW, Wood D. Attention deficit disorder ("minimal brain dysfunction") in adults. Arch Gen Psychiatry 1981;38:449-56.
32. Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N. A clinical and demographic profile of a sample adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 1990;31:416-25.